Dr. Wisniewski will give a lecture addressed to the general audience:
- Insights into Novel Therapies and the Pathogenesis of Alzheimer’s disease and the Possible Role of COVID-19
- The lecture will be presented as part of the KF Collegium of Eminent Scientists Lecture Series. Free and open to the public. Spots are limited. Registration is required.
Dr. Thomas Wisniewski will discuss studies conducted in his laboratory that describe molecular mechanism of formation and accumulation of amyloid plaques in the brain that lead to the pathogenesis of Alzheimer disease. Dr. Wisniewski’s lab developed active and passive immunization that specifically targets the components of amyloid plaques and the tests of this potential anti-Alzheimer vaccine in rodent and monkey models are encouraging. Dr. Wisniewski will also discuss possible mechanisms by which COVID infection may lead to similar dementia symptoms.
As the Alzheimer’s disease will exponentially rise in prevalence in the coming decades, there is a need for parallel development of early-stage detection and disease-modifying strategies, including vaccines for Alzheimer’s disease. Dr. Wisniewski’s work has helped to develop novel biomarkers and therapeutic approaches for treating Alzheimer’s disease, as well as means to stimulate innate immunity and improve patient’s health.
REGISTER >
Dr. Wisniewski has over 350 highly cited publications and 30 US patents.
APRIL 1, 2023 AT 4 PM at 4:00 PM.
An in person event at The Kosciuszko Foundation
